CERITINIB Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A member of the class of aminopyrimidines that is 2,6-diamino-5-chloropyrimidine in which the amino groups at positions 2 and 6 are respectively carrying 2-methoxy-4-(piperidin-4-yl)-5-methylphenyl and 2-(isopropylsulfonylamino)phenyl substituents. Used for the treatment of ALK-positive metastatic non-small cell lung cancer. (Chemical Entities of Biological Interest Ontology, CHEBI_78432)
External Link https://dgidb.org/results?searchType=drug&searchTerms=CERITINIB
Similar Terms
Downloads & Tools

Genes

13 interacting proteins for the CERITINIB drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
EML4 echinoderm microtubule associated protein like 4 3.18654
ALK anaplastic lymphoma receptor tyrosine kinase 2.70433
TSSK1B testis-specific serine kinase 1B 1.35723
ROS1 ROS proto-oncogene 1 , receptor tyrosine kinase 0.626414
NPM1 nucleophosmin (nucleolar phosphoprotein B23, numatrin) 0.407169
INSR insulin receptor 0.185077
IGF1R insulin-like growth factor 1 receptor 0.17703
MAP2K1 mitogen-activated protein kinase kinase 1 0.098113
NRAS neuroblastoma RAS viral (v-ras) oncogene homolog 0.0598778
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1 0.0389636
TP53 tumor protein p53 0.0265545
FLT3 fms-related tyrosine kinase 3 0.0181772
CYP3A4 cytochrome P450, family 3, subfamily A, polypeptide 4 0.00919118